The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/13118
StudyName: Eligibility Hormone-Refractory Prostate Cancer NCT01133704
Date of export from the portal: 02.07.2020
Date of Upload / last change: 17.01.2016
License: Creative Commons BY 4.0

----

Description: 
Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01133704
